News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 195
- Sources here
- 11
- Companies here
- 8
Search results
Stored financial headlines
Active search
195 matching headlines
Ticker or company: MINDMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Mind Technology Inc (MIND) Institutional Confidence
This article from TradingKey provides an overview of institutional confidence in Mind Technology Inc (MIND), detailing the shares held by various institutional investors. It lists several key shareholders, their holdings, and the percentage change in their holdings, indicating shifts in institutional investment over time. …
MIND
main company
Sharemaestro market context
Price below Trend Line
52 weeks -57.7%
MIND TECHNOLOGY, INC (MIND) grants director 30,000 options at $4.77 strike
MIND TECHNOLOGY, INC (MIND) director Thomas S. Glanville was granted 30,000 stock options with an exercise price of $4.77 per share. These options, which expire on July 29, 2036, will vest in three equal installments on July 29, 2027, 2028, and 2029. After this …
MIND
main company
Sharemaestro market context
Price below Trend Line
52 weeks -57.7%
MIND Technology, Inc. (MIND) grants director 30,000 stock options
MIND Technology, Inc. director William Hunter Hilarides was granted options to purchase 30,000 shares of common stock at an exercise price of $4.77 per share. These options are set to expire on July 29, 2036, and will vest in three equal annual installments from …
MIND
main company
Sharemaestro market context
Price below Trend Line
52 weeks -57.7%
Form 4 Mind Technology Inc For: 31 July By Investing.com
This article reports on a Form 4 filing for Mind Technology Inc., specifically detailing transactions made on July 31st. It also includes various market data such as indices, commodities, and trending stocks, along with links to other popular news and analysis from Investing.com. The …
MIND
main company
Sharemaestro market context
Price below Trend Line
52 weeks -57.7%
Mind Technology, Inc. (MIND) CEO awarded 60,000 options grant
Mind Technology, Inc.'s President and CEO, Robert P. Capps, has been granted 60,000 stock options at an exercise price of $4.77 per share. These options, which expire on July 26, 2036, will vest in three equal annual installments starting July 29, 2027. This transaction …
MIND
main company
Sharemaestro market context
Price below Trend Line
52 weeks -57.7%
Bright Minds Biosciences Inc. $DRUG Shares Bought by Vivo Capital LLC
Vivo Capital LLC increased its stake in Bright Minds Biosciences (NASDAQ:DRUG) by 11.1% in the first quarter, now holding 557,172 shares valued at $40.7 million. Several other institutional investors also increased their positions, bringing total institutional ownership to 40.52%. The company reported better-than-expected quarterly …
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Rating of "Buy" from Brokerages
Bright Minds Biosciences Inc. (NASDAQ:DRUG) has a consensus "Buy" rating from seven analysts, with an average 12-month price target of $143.83. The company, which is developing psychedelic-inspired treatments for mental health and neurodegenerative conditions, reported a quarterly loss of $0.80 per share, beating analyst …
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%
Mind CTI Ltd (MNDO) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Mind CTI Ltd (MNDO), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that MNDO has a price momentum score of 4.28 and is trading between a resistance level of 1.14 …
MNDO
main company
Sharemaestro market context
Price below Trend Line
52 weeks -12.1%
Bright Minds Biosciences Inc (DRUG) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides historical data on dividends and stock splits for Bright Minds Biosciences Inc (DRUG). It indicates that no dividends have been distributed in the past five years. The company executed several 5-for-1 merger-related stock splits on June 22, 2023.
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%
Mind Technology Inc (MIND) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Mind Technology Inc (MIND), focusing on its stock price, support and resistance levels, and various technical indicators. It notes that MIND is currently trading between $4.29 (support) and $5.62 (resistance) and gives a "Sell" signal from its …
MIND
main company
Sharemaestro market context
Price below Trend Line
52 weeks -57.7%
Mind CTI Ltd (MNDO) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis for Mind CTI Ltd (MNDO), detailing its current valuation score of 8.74, which ranks it 172 out of 485 in the Software & IT Services industry. It notes Mind CTI's current P/E ratio is 7.33, highlighting its position …
MNDO
main company
Sharemaestro market context
Price below Trend Line
52 weeks -12.1%
Mind Technology Inc (MIND) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Mind Technology
MIND
main company
Sharemaestro market context
Price below Trend Line
52 weeks -57.7%
ADAR1 Capital Management LLC Has $2.47 Million Stock Position in Bright Minds Biosciences Inc. $DRUG
ADAR1 Capital Management LLC significantly increased its stake in Bright Minds Biosciences Inc. (NASDAQ:DRUG) by 868.6% in the first quarter, now holding 33,900 shares valued at $2.47 million. Institutional investors collectively own 40.52% of the company, which reported a narrower-than-expected quarterly loss of $0.80 …
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%
Bright Minds Biosciences Market Sentiment
This article analyzes Bright Minds Biosciences (DRUG) market sentiment based on analyst consensus, short interest, options flow, and insider activity. It highlights a "Buy" consensus from 10 analysts with an average price target of $128, a 12.6% short float, and provides a detailed history …
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%
DRUG|Bright Minds Biosciences Inc|Price:70.680|Chg%:-1.280
This article provides an analysis of Bright Minds Biosciences Inc. (DRUG) through TradingKey's stock score system. It details the methodologies used to generate scores across various dimensions including financial health, valuation, earnings forecasts, price momentum, institutional confidence, and risk management. However, it explicitly states …
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%
Bright Minds Biosciences Inc (DRUG) Cash Flow
This article provides a detailed cash flow statement for Bright Minds Biosciences Inc (DRUG), covering operating, investing, and financing activities on a quarterly and annual basis. It presents extensive historical financial data, including net income, changes in working capital, and various components of cash …
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%
40,000 Shares in Bright Minds Biosciences Inc. $DRUG Acquired by Orbimed Advisors LLC
Orbimed Advisors LLC acquired 40,000 shares of Bright Minds Biosciences Inc. (NASDAQ:DRUG), a stake valued at approximately $2.9 million, contributing to institutional investors' 40.52% ownership. Analysts maintain a "Buy" rating with an average target price of $143.83, some raising targets and Zacks upgrading the …
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%
Mind CTI Ltd (MNDO) Cash Flow
This article provides a detailed historical cash flow statement for Mind CTI Ltd (MNDO), covering quarterly and annual data for operating, investing, and financing activities from FY2012Q1 to FY2026Q1. It also includes key financial figures such as market cap, P/E ratio, and recent stock …
MNDO
main company
Sharemaestro market context
Price below Trend Line
52 weeks -12.1%
Mind CTI Ltd (MNDO) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article details the dividend history for Mind CTI Ltd (MNDO), including payout amounts and key dates like ex-dividend, record, and payment dates for its final cash dividends. Over the past five years, the company has distributed a total of 20.13 million USD in …
MNDO
main company
Sharemaestro market context
Price below Trend Line
52 weeks -12.1%
Bright Minds Biosciences Inc (DRUG) Institutional Confidence
This article from TradingKey focuses on the institutional confidence in Bright Minds Biosciences Inc (DRUG). It lists the top institutional shareholders, their shareholdings, and the percentage change in their positions. The company's stock information, including market cap and recent price movements, is also provided.
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%
Mind CTI Ltd (MNDO) Shareholder Structure: Major Shareholders & Institutional Holdings
This article provides a detailed breakdown of the shareholder structure for Mind CTI Ltd (MNDO), including an overview of major individual and corporate shareholders and their respective proportions. It also presents a historical view of institutional holdings, showing changes in the number of institutions …
MNDO
main company
Sharemaestro market context
Price below Trend Line
52 weeks -12.1%